Press Releases

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.

Epilepsy patients set to benefit from non-invasive, real-time molecular breath analysis

Deep Breath Intelligence is pleased to announce the launch of DBI-EPIbreath®, a simple breath test that can provide reliable estimates of circulating concentrations of the antiseizure medication (ASM) valproic acid to aid patient management.

New resources from PATH & Accenture: Strengthening diagnostics supply security with local manufacturing and market-shaping interventions

Heart pacing company Ceryx Medical partners with Osypka Medical

Ceryx Medical Limited has announced a partnership with Berlin-based Osypka Medical to develop a heart pacing device that will change the way patients with heart failure and other cardiac conditions are treated.

DispatchHealth and Pathnostics Initiate Clinical Study to Compare Guidance UTI® Test to Standard Urine Culture Among Patients Receiving In-Home Care

Here is a link to the press release: https://www.prnewswire.com/news-releases/dispatchhealth-and-pathnostics-initiate-clinical-study-to-compare-guidance-uti-test-to-standard-urine-culture-among-patients-receiving-in-home-care-301634914.html?tc=eml_cleartime

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

Blue Earth Diagnostics announced that the FDA has accepted its filing for a New Drug Application for 18F-rhPSMA-7.3, an investigational radiohybrid Prostate-Specific Membrane Antigen-targeted (PSMA) PET imaging agent. The submission is for the use of 18F-rhPSMA-7.3 PET for diagnostic imaging of prostate cancer.

CD BioGlyco Supports Glycan Separation and Purification with Advanced Techniques

Profacgen Enhanced Its Structure-based Virtual Screening (SBVS) Service Recently

Creative Biostructure Uncovers Insights for Pathology Research with Advanced iEM Platform

Alfa Chemistry Newly Releases Biological Stains for Laboratory and Diagnostic Use

BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS

BioIVT Acquires Fidelis Research

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research

Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection

CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery

Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins